Waters Co. (NYSE:WAT) Shares Acquired by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC lifted its stake in shares of Waters Co. (NYSE:WATFree Report) by 8.9% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,942 shares of the medical instruments supplier’s stock after purchasing an additional 321 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Waters were worth $1,081,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. First Capital Advisors Group LLC. bought a new position in shares of Waters during the second quarter worth about $26,000. Institutional & Family Asset Management LLC bought a new position in Waters in the second quarter worth about $27,000. West Tower Group LLC bought a new position in Waters in the second quarter worth about $28,000. Harbour Investments Inc. lifted its holdings in Waters by 11,000.0% in the second quarter. Harbour Investments Inc. now owns 111 shares of the medical instruments supplier’s stock worth $30,000 after acquiring an additional 110 shares during the last quarter. Finally, Clear Street Markets LLC lifted its holdings in Waters by 94.9% in the first quarter. Clear Street Markets LLC now owns 115 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 56 shares during the last quarter. Institutional investors own 94.01% of the company’s stock.

Waters Price Performance

NYSE WAT opened at $322.82 on Monday. Waters Co. has a 12 month low of $231.90 and a 12 month high of $341.94. The company has a debt-to-equity ratio of 2.71, a current ratio of 0.69 and a quick ratio of 0.47. The firm has a market capitalization of $19.09 billion, a PE ratio of 29.75, a P/E/G ratio of 6.42 and a beta of 0.92. The company’s 50 day simple moving average is $315.13 and its 200 day simple moving average is $285.33.

Waters (NYSE:WATGet Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The medical instruments supplier reported $3.62 EPS for the quarter, beating analysts’ consensus estimates of $3.56 by $0.06. Waters had a net margin of 21.72% and a return on equity of 81.30%. The business had revenue of $819.50 million for the quarter, compared to analyst estimates of $815.50 million. During the same quarter last year, the business earned $3.84 earnings per share. The business’s revenue for the quarter was down 4.5% on a year-over-year basis. As a group, equities research analysts forecast that Waters Co. will post 11.89 EPS for the current fiscal year.

Analysts Set New Price Targets

WAT has been the topic of a number of recent research reports. JPMorgan Chase & Co. cut their target price on shares of Waters from $260.00 to $250.00 and set a “neutral” rating on the stock in a report on Wednesday, November 8th. Wolfe Research began coverage on shares of Waters in a report on Wednesday, December 13th. They issued a “peer perform” rating on the stock. Wells Fargo & Company dropped their price target on shares of Waters from $305.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 8th. Stifel Nicolaus raised their price target on shares of Waters from $290.00 to $330.00 and gave the company a “hold” rating in a research note on Wednesday, February 7th. Finally, TheStreet upgraded shares of Waters from a “c+” rating to a “b-” rating in a research note on Wednesday, December 13th. One analyst has rated the stock with a sell rating and eight have given a hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $290.38.

Get Our Latest Stock Analysis on WAT

Waters Profile

(Free Report)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.